Approval · Notice of Compliance 33433 · 2024
LIBTAYO: Notice of Compliance 33433
Issued June 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33433
- Date
- June 11, 2024
- Company
- Regeneron Canada CompanyMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative - Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIBTAYO | 02487144 | Marketed |
Medicinal ingredients
- CEMIPLIMAB 350 MG per 7ML